5 ML valproic acid 100 MG/ML Injection — RxCUI 1099648
RxNorm drug concept · Semantic clinical drug
RxCUI 1099648
Semantic clinical drug · SCD
● Current RxNorm concept 5 FDA products
5 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1099648
Official name5 ML valproic acid 100 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known as5 ML VPA 100 MG/ML Injection; valproic acid 500 MG in 5 ML Injection; valproic acid 500 MG per 5 ML Injection
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)545 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Divalproex: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats seizures, manic episodes of bipolar disorder, and prevents migraines. Which uses apply depends on the product. Capsules are only for seizures. Ask me to check which one y...
- Swallow tablets whole and never crush or chew them. Extended-release tablets are once a day. Capsules can be swallowed whole or sprinkled on soft food and swallowed right away. Tak...
- For delayed-release tablets, take it as soon as you remember unless it is almost time for the next dose. Do not double up. Ask your prescriber if you take another form.
- Nausea, stomach upset, sleepiness, dizziness, tremor, headache and hair loss are common. Call your doctor if they bother you a lot. Call right away for severe stomach pain, vomitin...
🕸️ Concept Web — How 5 ML valproic acid 100 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
5 ML valproic acid 100 MG/ML Injection
RxCUI 1099648 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Valproate
40254IN -
Valproic acid
11118PIN
-
Valproate
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Valproate Injection
1867729SCDF -
Valproic acid Injection
2649242SCDFP -
Valproate Injectable Product
1159994SCDG -
Valproic acid Injectable Product
2660600SCDGP -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Valproate Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Valproic acid 100 MG/ML
1099647SCDC
-
Valproic acid 100 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Valproic acid 100 MG/ML
SCDC · 1099647 -
Valproate Injection
SCDF · 1867729 -
Valproic acid Injection
SCDFP · 2649242 -
Valproate Injectable Product
SCDG · 1159994 -
Valproic acid Injectable Product
SCDGP · 2660600
📦 FDA Products & Package NDCs
5 products · 5 package NDCs
5 package NDCs map to RxCUI 1099648 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9637-10 | 10 VIAL, SINGLE-DOSE in 1 TRAY (0143-9637-10) / 5 mL in 1 V... | Valproate Sodium | Hikma Pharmaceuticals USA Inc. | 2013-04-15 |
| 00143-9785-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0143-9785-10) / 5 mL in 1... | Valproate Sodium | Hikma Pharmaceuticals USA Inc. | 2010-02-17 |
| 25021-0797-05 | 10 VIAL in 1 CARTON (25021-797-05) / 5 mL in 1 VIAL | Valproate Sodium | Sagent Pharmaceuticals | 2024-12-01 |
| 63323-0494-05 | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-494-05) / 5 mL in 1 V... | Valproate Sodium | Fresenius Kabi USA, LLC | 2003-08-18 |
| 63323-0494-16 | 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-494-16) / 5 mL in 1 V... | Valproate Sodium | Fresenius Kabi USA, LLC | 2003-08-18 |
Observed labelers:
Fresenius Kabi USA, LLC (2) ·
Hikma Pharmaceuticals USA Inc. (2) ·
Sagent Pharmaceuticals (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J3379 | Inj, valproate sod, 5 mg | 5 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.